Solid Biosciences Inc. Contracts & Agreements
96 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (3)
- Human Resources (45)
- Intellectual Property (12)
- Mergers & Acquisitions (5)
- Real Estate (4)
- Uncategorized (12)
- Employment Agreement, dated October 2, 2023, by and between Solid Biosciences Inc. and Gabriel Brooks (Filed With SEC on November 8, 2023)
- Consulting Agreement dated as of July 14, 2023, between Solid Biosciences Inc. and PHDL Consulting LLC (Filed With SEC on August 14, 2023)
- Executive Transition and Separation Agreement, dated as of May 22, 2023, between Solid Biosciences Inc. and Carl Morris (Filed With SEC on August 14, 2023)
- Employment Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and David Tyronne Howton (Filed With SEC on May 11, 2023)
- Executive Transition and Separation Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and Ilan Ganot (Filed With SEC on September 30, 2022)
- Consulting Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and Erin Powers Brennan (Filed With SEC on September 30, 2022)
- Executive Transition and Separation Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and Erin Powers Brennan (Filed With SEC on September 30, 2022)
- Consulting Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and Ilan Ganot (Filed With SEC on September 30, 2022)
- Employment Agreement, dated September 29, 2022, by and between Solid Biosciences Inc. and Alexander Cumbo (Filed With SEC on September 30, 2022)
- Registration Rights Agreement, dated September 29, 2022, by and among Solid Biosciences Inc. and the persons party thereto (Filed With SEC on September 30, 2022)
- Securities Purchase Agreement, dated September 29, 2022, by and among Solid Biosciences Inc. and the persons party thereto (Filed With SEC on September 30, 2022)
- Form of Support and Joinder Agreement (Filed With SEC on September 30, 2022)
- Form of Parent Support Agreement (Filed With SEC on September 30, 2022)
- Agreement and Plan of Merger, dated as of September 29, 2022, by and among Solid Biosciences Inc., Greenland Merger Sub LLC, AavantiBio, Inc. and, solely in his capacity as the... (Filed With SEC on September 30, 2022)
- Summary of Non-Employee Director Compensation Policy (Filed With SEC on August 11, 2022)
- Form of Restricted Stock Unit Agreement under the 2020 Equity Incentive Plan (Filed With SEC on March 14, 2022)
- 2020 Equity Incentive Plan, as amended by Amendment No. 1 to 2020 Stock Incentive Plan (Filed With SEC on March 14, 2022)
- Executive Chair Agreement, effective January 1, 2022, by and between Solid Biosciences Inc. and Ian F. Smith (Filed With SEC on March 14, 2022)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on March 14, 2022)
- Employment Agreement, dated as of March 1, 2021, by and between Solid Biosciences Inc. and Erin Powers Brennan (Filed With SEC on March 14, 2022)
- Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Joel Schneider (Filed With SEC on March 14, 2022)
- Amendment No. 1 to Sublease, dated as of December 3, 2021, by and between Solid Biosciences, LLC and Twitter, Inc (Filed With SEC on March 14, 2022)
- Form of Nonstatutory Inducement Stock Option Agreement (Filed With SEC on August 16, 2021)
- Lease, dated June 15, 2021, between Solid Biosciences, Inc. and Hood Park LLC (Filed With SEC on August 16, 2021)
- Consulting Agreement, dated as of January 4, 2021, by and between Solid Biosciences Inc. and Ian F. Smith (Filed With SEC on May 14, 2021)
- Underwriting Agreement, dated March 18, 2021, by and among the Company and Jefferies LLC, SVB Leerink LLC and Piper Sandler & Co (Filed With SEC on March 19, 2021)
- Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Jennifer Ziolkowski (Filed With SEC on March 15, 2021)
- Consulting Agreement, dated as of November 19, 2020, by and between Solid Biosciences Inc. and Danforth Advisors, LLC (Filed With SEC on March 15, 2021)
- First Amendment, dated as of January 27, 2021, to the Exclusive Patent License by and between the Company and the Curators of the University of Missouri (Filed With SEC on March 15, 2021)
- Securities Purchase Agreement, dated December 10, 2020, by and among the Company and the other parties thereto (Filed With SEC on December 11, 2020)
- Registration Rights Agreement, dated December 10, 2020, by and among the Company and the other parties thereto (Filed With SEC on December 11, 2020)
- Stock Purchase Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc (Filed With SEC on November 5, 2020)
- First Amendment, dated as of October 9, 2020, to the Exclusive Patent License by and between the Company and the University of Washington (Filed With SEC on November 5, 2020)
- Investor Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc (Filed With SEC on November 5, 2020)
- Collaboration and License Agreement, dated as of October 22, 2020, by and between the Company and Ultragenyx Pharmaceutical Inc (Filed With SEC on November 5, 2020)
- Form of Restricted Stock Unit Agreement under the 2020 Equity Incentive Plan (Filed With SEC on August 6, 2020)
- Form of Stock Option Agreement under the 2020 Equity Incentive Plan (Filed With SEC on August 6, 2020)
- Consulting Agreement, dated as of June 16, 2020, by and between Solid Biosciences Inc. and Ian F. Smith (Filed With SEC on August 6, 2020)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on August 6, 2020)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on May 7, 2020)
- Consulting Agreement, dated as of February 1, 2020, by and between Solid Biosciences Inc. and Ian F. Smith (Filed With SEC on May 7, 2020)
- Consulting Agreement, dated as of January 15, 2020 by and between Solid Biosciences Inc. and Jorge Quiroz (Filed With SEC on March 12, 2020)
- Consulting Agreement, dated as of January 15, 2020, by and between Solid Biosciences Inc. and Alvaro Amorrortu (Filed With SEC on March 12, 2020)
- Consulting Agreement, dated as of January 1, 2020, by and between Solid Biosciences Inc. and Andrey Zarur (Filed With SEC on March 12, 2020)
- Description of the Companys Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 12, 2020)
- Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Jorge Quiroz (Filed With SEC on March 12, 2020)
- Registration Rights Agreement, dated July 25, 2019, by and among the Company and the other parties thereto (Filed With SEC on July 26, 2019)
- Form of Pre-Funded Warrant to Purchase Common Stock to be issued pursuant to the Securities Purchase Agreement (Filed With SEC on July 26, 2019)
- Securities Purchase Agreement, dated July 25, 2019, by and among the Company and the other parties thereto (Filed With SEC on July 26, 2019)
- Consulting Agreement, dated as of January 1, 2019, by and between Solid Biosciences Inc. and Andrey Zarur (Filed With SEC on May 13, 2019)
- Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Alvaro Amorrortu (Filed With SEC on March 13, 2019)
- Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Carl Morris. Ph.D (Filed With SEC on March 13, 2019)
- Form of Incentive Stock Option Agreement under 2018 Omnibus Incentive Plan (Filed With SEC on March 13, 2019)
- Form of Nonqualified Stock Option Agreement under 2018 Omnibus Incentive Plan (Filed With SEC on March 13, 2019)
- Employment Agreement, dated as of January 25, 2019, by and between Solid Biosciences Inc. and Ilan Ganot (Filed With SEC on March 13, 2019)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on March 13, 2019)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on November 13, 2018)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on August 10, 2018)
- Agreement and Plan of Merger, dated January 25, 2018, by and among Solid Biosciences Inc., Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP, BCLS Solid... (Filed With SEC on March 29, 2018)
- Plan of Conversion, dated January 25, 2018 (Filed With SEC on March 29, 2018)
- Solid Biosciences, LLC Amended and Restated Equity Incentive Plan and form of unit restriction agreement (Filed With SEC on March 29, 2018)
- Sublease, dated as of January 30, 2018, by and between Solid Biosciences, LLC and Twitter, Inc (Filed With SEC on March 29, 2018)
- Lease Agreement, dated as of December 22, 2017, by and between Solid Biosciences, LLC and ARE-MA Region No. 59, LLC (Filed With SEC on March 29, 2018)
- Form of Solid Biosciences Inc. 2018 Omnibus Incentive Plan (Filed With SEC on January 24, 2018)
- Form of Agreement and Plan of Merger (Filed With SEC on January 16, 2018)
- Amendment to Offer Letter, dated November 17, 2017, by and between Solid Biosciences, LLC and Jennifer Ziolkowski (Filed With SEC on January 16, 2018)
- License Agreement, dated as of November 20, 2016, by and between Solid Biosciences, LLC and Life Technologies Corporation (Filed With SEC on January 16, 2018)
- Form of Plan of Conversion (Filed With SEC on January 16, 2018)
- Offer Letter, dated as of April 17, 2017, by and between Solid Biosciences, LLC and Jennifer Ziolkowski (Filed With SEC on January 16, 2018)
- Form of Solid Biosciences Inc. 2018 Omnibus Incentive Plan (Filed With SEC on January 16, 2018)
- License Agreement, dated as of March 10, 2016, by and between Solid GT, LLC and the Regents of the University of Michigan (Filed With SEC on January 16, 2018)
- First Amendment to Patent License Agreement, dated as of March 15, 2017, by and between Solid GT, LLC and the Regents of the University of Michigan (Filed With SEC on January 16, 2018)
- License Agreement, dated as of October 15, 2015, by and between Solid GT, LLC and The Curators of the University of Missouri (Filed With SEC on January 16, 2018)
- Form of Restricted Stock Agreement under 2018 Omnibus Plan (Filed With SEC on December 29, 2017)
- Form of Underwriting Agreement (Filed With SEC on December 29, 2017)
- Agreement and Plan of Merger, dated March 29, 2017, by and between Solid Biosciences, LLC and Solid GT, LLC (Filed With SEC on December 29, 2017)
- Amended and Restated Registration Rights Agreement dated March 29, 2017 by and among Solid Biosciences, LLC and certain investors (Filed With SEC on December 29, 2017)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on December 29, 2017)
- License Agreement, dated as of August 3, 2017, by and between Solid Biosciences, LLC and the President and Fellows of Harvard College (Filed With SEC on December 29, 2017)
- License Agreement, dated as of June 23, 2016, by and between Solid GT, LLC and the President and Fellows of Harvard College (Filed With SEC on December 29, 2017)
- License Agreement, dated as of November 20, 2016, by and between Solid Biosciences, LLC and Licensor (Filed With SEC on December 29, 2017)
- License Agreement, dated as of October 15, 2015, by and between Solid GT, LLC and The Curators of the University of Missouri (Filed With SEC on December 29, 2017)
- License Agreement, dated as of March 10, 2016, by and between Solid GT, LLC and the Regents of the University of Michigan (Filed With SEC on December 29, 2017)
- License Agreement, dated as of October 16, 2015, by and between Solid GT, LLC and the University of Washington (Filed With SEC on December 29, 2017)
- Form of Plan of Conversion (Filed With SEC on December 29, 2017)
- Form of Nonqualified Stock Option Agreement under 2018 Omnibus Incentive Plan (Filed With SEC on December 29, 2017)
- Form of Incentive Stock Option Agreement under 2018 Omnibus Incentive Plan (Filed With SEC on December 29, 2017)
- Form of Solid Biosciences Inc. 2018 Omnibus Incentive Plan (Filed With SEC on December 29, 2017)
- Solid Biosciences, LLC Amended and Restated Equity Incentive Plan (Filed With SEC on December 29, 2017)
- Advisory Agreement, dated as of December 28, 2013, by and between Solid Ventures, LLC and Andrey Zarur (Filed With SEC on December 29, 2017)
- Offer Letter, dated as of November 6, 2015, by and between Solid Biosciences, LLC and Alvaro Amorrortu (Filed With SEC on December 29, 2017)
- Offer Letter, dated as of November 17, 2015, by and between Solid GT, LLC and Jorge A. Quiroz, M.D (Filed With SEC on December 29, 2017)
- Employment Agreement, dated as of December 27, 2013, by and between Solid Ventures, LLC and Ilan Ganot (Filed With SEC on December 29, 2017)
- Form of Common Stock Certificate (Filed With SEC on December 29, 2017)
- Form of Certificate of Conversion of Solid Biosciences, LLC (Filed With SEC on December 29, 2017)
- Form of Agreement and Plan of Merger (Filed With SEC on December 29, 2017)